GlassScriptPhysician profile
Katelon Marie Smith
NPI 1033673405
$7,243.43
in general payments reported to CMS, 2019-2025
50 companies · $1,943 in 2025
The $1,943 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $778 · 2022: $1,084 · 2023: $1,814 · 2024: $1,624 · 2025: $1,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,381.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,313.49 | 2021-2025 | |
| Lilly USA, LLC | $416.84 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $339.32 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Otsuka America Pharmaceutical, INC. | $333.03 | 2021-2025 | Rexulti |
| Amgen INC. | $319.99 | 2022-2025 | Otezla, Repatha, Repatha |
| Lundbeck LLC | $313.21 | 2022-2025 | Vyepti, Rexulti |
| Novo Nordisk INC | $282.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $252.06 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $243.84 | 2022-2025 | Caplyta |
| Novartis Pharmaceuticals Corporation | $186.18 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.88 | 2021-2025 | Xifaxan, Trulance |
| Alnylam Pharmaceuticals INC. | $147.34 | 2025 | Amvuttra, Onpattro |
| Biohaven Pharmaceuticals, INC. | $141.73 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $134.32 | 2022-2024 | Farxiga, Flumist Quadrivalent, Evusheld |
| Teva Pharmaceuticals USA, INC. | $120.78 | 2025 | Uzedy |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $116.87 | 2022 | |
| Glaxosmithkline, LLC. | $109.27 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Corcept Therapeutics | $98.96 | 2024-2025 | Korlym |
| Astellas Pharma US INC | $91.97 | 2024-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $77.85 | 2023-2025 | Hyqvia |
| Xeris Pharmaceuticals, INC. | $73.66 | 2022-2025 | Gvoke Hypopen |
| Dexcom, INC. | $72.39 | 2022-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $57.18 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $56.61 | 2024 | Evkeeza, Praluent |
| Averitas Pharma INC. | $54.30 | 2023-2024 | Qutenza |
| Paratek Pharmaceuticals, INC. | $52.11 | 2021-2023 | Nuzyra |
| Aimmune Therapeutics, INC. | $48.19 | 2024-2025 | Vowst, Zenpep |
| Biogen, INC. | $47.83 | 2021-2022 | |
| Exact Sciences Corporation | $46.36 | 2023-2025 | Cologuard Collection Kit |
| Alkermes, INC. | $42.78 | 2022-2023 | Vivitrol |
| Axsome Therapeutics, INC. | $38.67 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $38.44 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $35.80 | 2021 | |
| Ironwood Pharmaceuticals, INC | $33.42 | 2023 | Linzess |
| Verona Pharma, INC. | $32.93 | 2025 | Ohtuvayre |
| Jazz Pharmaceuticals INC. | $28.15 | 2021 | |
| Organogenesis INC. | $24.67 | 2023 | Puraply |
| Daiichi Sankyo INC. | $24.44 | 2022 | |
| Kci USA, INC. | $23.24 | 2023 | V.A.C. Dermatac, Activ.A.C., 3m Cavilon |
| Tg Therapeutics, INC. | $22.90 | 2023 | |
| Ardelyx, INC. | $21.51 | 2024 | Ibsrela |
| Melinta Therapeutics, LLC | $21.41 | 2023 | Orbactiv, Kimyrsa |
| Ultragenyx Pharmaceutical INC. | $20.92 | 2023 | |
| Sumitomo Pharma America, INC. | $18.54 | 2025 | Gemtesa |
| Celltrion USA INC. | $18.47 | 2025 | Vegzelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.26 | 2023 | Spevigo |
| Supernus Pharmaceuticals, INC. | $17.95 | 2023 | Qelbree |
| Hologic Sales and Service, LLC | $16.05 | 2023 | Aptima, Thinprep 2000 Processor |
| Currax Pharmaceuticals LLC | $13.12 | 2021 | |
| Phathom Pharmaceuticals, INC. | $9.30 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.